PepGel, founded in Manhattan, Kansas, focuses on innovating tissue engineering and organ regeneration through advanced hydrogel technology. Their core mission is to enhance life science and medical research by providing cutting-edge cell culture systems and 3D drug testing platforms. PepGel's products and services include cell or spheroid expansions, in vivo delivery systems, wound healing solutions, and bioink printing for tissue engineering.
Notable affiliated individuals and investors remain undisclosed, but the company's key achievements include the development of a self-healing hydrogel that transitions easily between liquid and gel states, revolutionizing cell culture and drug discovery processes. PepGel has significantly impacted the fields of tissue engineering and regenerative medicine, providing essential tools for researchers and clinicians worldwide.
